Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy
NCT06980350
·
clinicaltrials.gov ↗
COMPLETED
Status
156
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
PD-1 Inhibitors
Sponsor
Sun Yat-sen University